As frustrating that it is, I think you are correct. Short term...

As frustrating that it is, I think you are correct. Short term frustration for us holders is that a lot of analysts disregard companies that are yet to make a profit in what seems a fairly boring industry and have their favourites for different reasons. Fair enough as they have a lot of different companies and sectors to cover and might not have the time to do their due diligence as much as we have.

Let’s see what happens when we declare a profit and trials are done and accepted for deep thickness burns/ trauma in the US. Let’s remember surgeon’s have proved it works, just need the clinical data behind it